Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Brain Neoplasms 5Squamous Cell Carcinoma of Head and Neck 4Polycythemia Vera 4Glioblastoma 4Meningioma 3Leukemia, Myeloid, Acute 3Pharyngeal Neoplasms 2Paranasal Sinus Neoplasms 2Neoplasms 2Laryngeal Neoplasms 2Head and Neck Neoplasms 2Gliosarcoma 2Thrombocytosis 1Thrombocythemia, Essential 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Papillomavirus Infections 1Oropharyngeal Neoplasms 1Nose Neoplasms 1Myeloproliferative Disorders 1Myelodysplastic Syndromes 1Lymphoma, Non-Hodgkin 1Hodgkin Disease 1Glioma 1Epstein-Barr Virus Infections 1Carcinoma, Squamous Cell 1Carcinoma 1Astrocytoma 1Adenocarcinoma 1

Interventions

Rituximab 155Cyclophosphamide 120fludarabine phosphate 71Whole-Body Irradiation 55Mycophenolic Acid 54Etoposide 53Peripheral Blood Stem Cell Transplantation 46fludarabine 45Melphalan 44Granulocyte Colony-Stimulating Factor 43Busulfan 43Tacrolimus 39Filgrastim 37Vincristine 33Cyclosporine 31Bendamustine Hydrochloride 31Prednisone 29Doxorubicin 29Antilymphocyte Serum 28Methotrexate 27Cytarabine 27Lenalidomide 23Carmustine 22Bortezomib 22plerixafor 20Dexamethasone 19Thiotepa 17Stem Cell Transplantation 17Radiotherapy 17tositumomab I-131 16

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Lymphoma, Non-Hodgkin × Hydroxyurea × Clear all
NCT01964755 2019-09-23

Chemotherapy for Relapsed Epstein Barr Virus Associated Lymphoma

University of Miami

Phase 2 Terminated
6 enrolled 14 charts
Lymphoid

Hodgkin Disease, Lymphoma, Non-Hodgkin, Epstein-Barr Virus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡